New Key Statistics Module, Z-Score and F-Score
NYSE:CC Key Ratios
| Market Cap $ M | 2,302.64 |
| Enterprise Value $ M | 5,752.64 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 21.55 |
| Forward PE Ratio | 7.92 |
| Price/Book | -- |
| Price/Sales | 0.40 |
| Price/Free Cash Flow | 10.63 |
| Price/Owner Earnings | 6.67 |
| Payout Ratio % | 0.50 |
| Revenue (TTM) $ M | 5,797.00 |
| EPS (TTM) $ | -2.01 |
| Beneish M-Score | -3.18 |
| 10-y EBITDA Growth Rate % | 0.70 |
| 5-y EBITDA Growth Rate % | -16.70 |
| y-y EBITDA Growth Rate % | 74.00 |
| EV-to-EBIT | 24.58 |
| EV-to-EBITDA | 10.40 |
| PEG | -- |
| Shares Outstanding M | 150.50 |
| Net Margin (%) | -5.24 |
| Operating Margin % | -1.43 |
| Pre-tax Margin (%) | -0.67 |
| Quick Ratio | 0.88 |
| Current Ratio | 1.66 |
| ROA % (ttm) | -4.12 |
| ROE % (ttm) | -159.83 |
| ROIC % (ttm) | -1.57 |
| Dividend Yield % | 2.29 |
| Altman Z-Score | 1.49 |
CC Number of Guru Trades
CC Volume of Guru Trades
Gurus Latest Trades with NYSE:CC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:CC is held by these investors
Total 5
The Chemours Co Insider Transactions
No Available Data
News about NYSE:CC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers